Cost Analysis of DPP4 and SGLT2 Inhibitors - “Dilemma of the Prescribing Physician - Which Brand to Choose?”

Cost Analysis of DPP4 and SGLT2 Inhibitors - “Dilemma of the Prescribing Physician - Which Brand to Choose?”

Diabetes mellitus (DM) is a complex and heterogeneous group of chronic metabolic diseases causing dreaded complications increasing human sufferings, and a costly disease to manage in low/middle-income countries, which is burdensome for the most vulnerable populations, cause financial strain...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiteswar Saikia, Prabhat Ranjan Baruah, Anju L Saikia
Format: Article
Language:English
Published: Krupanidhi College of Pharmacy 2024-06-01
Series:Journal of Pharmaceutical Research
Online Access:https://jopcr.com/articles/cost-analysis-of-dpp4-and-sglt2-inhibitors-dilemma-of-the-prescribing-physician-which-brand-to-choose
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jopcr.com/articles/cost-analysis-of-dpp4-and-sglt2-inhibitors-dilemma-of-the-prescribing-physician-which-brand-to-choose

Similar Items